Search research articles
Contact Us
Filters
Showing results (231-240 of 274) with videos related to
Page
of 28
Sort By:
Neurology
|
February 17, 2021
Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias
Erica Howard, David J Irwin, Katya Rascovsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 16, 2017
A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors
Andrea E Wahner Hendrickson, Michael E Menefee, Lynn C Hartmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2016
A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia
Keith W Pratz, Michelle A Rudek, Ivana Gojo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 8, 2015
The NINDS Parkinson's disease biomarkers program
Liana S Rosenthal, Daniel Drake, Roy N Alcalay, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 4, 2024
Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of Frontotemporal Dementia
Yanaika S Hok-A-Hin, Lisa Vermunt, Carel F W Peeters, et al.
Nature Communications
|
November 12, 2024
Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discovery
Jessica Karielle Tan, Venice Servellita, Doug Stryke, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2025
Inflammatory disease microbiomes share a functional pathogenicity predicted by C-reactive protein
Graham J Britton, Ilaria Mogno, Alice Chen-Liaw, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 28, 2013
A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank
Jon B Toledo, Vivianna M Van Deerlin, Edward B Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2018
Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer
M Catherine Pietanza, Saiama N Waqar, Lee M Krug, et al.
Brain : a Journal of Neurology
|
June 22, 2023
CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease
Emma L van der Ende, Sjors G J G In 't Veld, Iris Hanskamp, et al.
Page
of 28
Search research articles
Search
Showing results (231-240 of 274) with videos related to
Sort By:
Page
of 28
Neurology
|
February 17, 2021
Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias
Erica Howard, David J Irwin, Katya Rascovsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 16, 2017
A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors
Andrea E Wahner Hendrickson, Michael E Menefee, Lynn C Hartmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2016
A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia
Keith W Pratz, Michelle A Rudek, Ivana Gojo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 8, 2015
The NINDS Parkinson's disease biomarkers program
Liana S Rosenthal, Daniel Drake, Roy N Alcalay, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 4, 2024
Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of Frontotemporal Dementia
Yanaika S Hok-A-Hin, Lisa Vermunt, Carel F W Peeters, et al.
Nature Communications
|
November 12, 2024
Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discovery
Jessica Karielle Tan, Venice Servellita, Doug Stryke, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2025
Inflammatory disease microbiomes share a functional pathogenicity predicted by C-reactive protein
Graham J Britton, Ilaria Mogno, Alice Chen-Liaw, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 28, 2013
A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank
Jon B Toledo, Vivianna M Van Deerlin, Edward B Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2018
Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer
M Catherine Pietanza, Saiama N Waqar, Lee M Krug, et al.
Brain : a Journal of Neurology
|
June 22, 2023
CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease
Emma L van der Ende, Sjors G J G In 't Veld, Iris Hanskamp, et al.
Page
of 28